All products / DC11300
SPR-00305
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $2,500 USDRequest a quote / confirm availability → |
| 250 mg | $3,500 USDRequest a quote / confirm availability → |
| 1 g | $4,500 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
SPR-00305 is a potent MvfR inhibitor and displays target engagement. SPR-00305, potently inhibited the MvfR pathway with IC50s of 115 nM against 4-hydroxy-2-heptylquinoline (HHQ), 93 nM against pyocyanin (PYO) and 109 nM against 3,4-dihydroxy-2-heptoquinoline (PQS) in PA14. The compound was further tested in the immunocompetent acute thigh infection model. It decreased PQS by 50% and HHQ by 40% in comparison with vehicle. In the neutropenic acute thigh infection model, SPR-00305 oral administration (200 mg) resulted in a slight decrease in HHQ levels.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC11300 |
|---|---|
| Product name | SPR-00305 |
| CAS | 1965261-97-5 |
| Molecular formula | C24H19ClN2O3 |
| Molecular weight | 418.877 |
| Purity | >98% |
| SMILES | NC(=O)c1cc2cc(Cl)ccc2cc1OCC(=O)c1c[nH]c2cc(C3CC3)ccc12 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — SPR-00305 (DC11300)